Gene therapy for urologic cancer.
Advances in molecular technology and the completion of the human genome project have ushered in a new era of medicine, that of gene therapy. In every field of medicine, investigators are developing gene therapeutics in an attempt to cure diseases. Urologic oncology is no exception. Herein, we review the current status of gene therapy for urologic malignancy. Included is an overview of advances in gene delivery systems and immunology, which are driving forces for gene therapy research. Finally, we review the current gene therapy trials and experimental approaches for urologic malignancy.
Ferrer
Fernando A
FA
Department of Pediatric Urology, Connecticut Children's Medical Center, University of Connecticut, 282 Washington Street, Hartford, CT 06106, USA. fferrer@ccmckids.org
Rodriguez
Ronald
R
D002292:Carcinoma, Renal Cell / Q000628:therapy; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy; D014571:Urologic Neoplasms / Q000628:therapy*